{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:15:41Z","timestamp":1791270941646,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.expneurol.2010.02.006","type":"journal-article","created":{"date-parts":[[2010,2,25]],"date-time":"2010-02-25T05:46:18Z","timestamp":1267076778000},"page":"599-608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Neurophysiological, histological and immunohistochemical characterization of bortezomib-induced neuropathy in mice"],"prefix":"10.1016","volume":"223","author":[{"given":"Jordi","family":"Bruna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Udina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Al\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge J.","family":"Vilches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Vynckier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Monbaliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2010.02.006_bib1","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1182\/blood-2008-04-149385","article-title":"Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature","volume":"112","author":"Argyriou","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.expneurol.2010.02.006_bib2","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/j.1460-9568.2004.03241.x","article-title":"NGF and GDNF ameliorate the increase in ATF3 expression which occurs in dorsal root ganglion cells in response to peripheral nerve injury","volume":"19","author":"Averill","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.02.006_bib3","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/sj.bjc.6604347","article-title":"Bortezomib\/docetaxel combination therapy in patients with anthracycline-pretreated advanced\/metastatic breast cancer: a phase I\/II dose-escalation study","volume":"98","author":"Awada","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.expneurol.2010.02.006_bib4","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/cncr.22921","article-title":"Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature","volume":"110","author":"Badros","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.expneurol.2010.02.006_bib5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1532\/IJH97.A30512","article-title":"A multicenter retrospective analysis of adverse events in Korean patients using bortezomib for multiple myeloma","volume":"83","author":"Bang","year":"2006","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.expneurol.2010.02.006_bib6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejca.2008.08.011","article-title":"An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer","volume":"45","author":"Caponigro","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.expneurol.2010.02.006_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12640-009-9086-1","article-title":"Bortezomib induces the formation of nuclear poly(A) RNA granules enriched in Sam68 and PABPN1 in sensory ganglia neurons","volume":"17","author":"Casafont","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.expneurol.2010.02.006_bib8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.expneurol.2009.01.014","article-title":"Nociceptive responses and spinal plastic changes of afferent C-fibers in three neuropathic pain models induced by sciatic nerve injury in the rat","volume":"217","author":"Casals-Diaz","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2010.02.006_bib9","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jpain.2006.09.014","article-title":"Quantitative sensory findings in patients with bortezomib-induced pain","volume":"8","author":"Cata","year":"2007","journal-title":"J. Pain"},{"key":"10.1016\/j.expneurol.2010.02.006_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.expneurol.2006.11.010","article-title":"Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat","volume":"204","author":"Cavaletti","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2010.02.006_bib11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/cne.21537","article-title":"Chronic nerve compression injury induces a phenotypic switch of neurons within the dorsal root ganglia","volume":"506","author":"Chao","year":"2008","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2010.02.006_bib12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1529-8027.2008.00193.x","article-title":"Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy","volume":"13","author":"Chaudhry","year":"2008","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.expneurol.2010.02.006_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/JTO.0b013e3181915052","article-title":"Bortezomib plus gemcitabine\/carboplatin as first-line treatment of advanced non-small cell lung cancer: a phase II Southwest Oncology Group Study (S0339)","volume":"4","author":"Davies","year":"2009","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.expneurol.2010.02.006_bib14","first-page":"187","article-title":"Histologic assessment of sciatic nerve regeneration following resection and graft or tube repair in the mouse","volume":"10","author":"G\u00f3mez","year":"1996","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.expneurol.2010.02.006_bib15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia","volume":"32","author":"Hargreaves","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2010.02.006_bib16","first-page":"1498","article-title":"Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study","volume":"91","author":"Harousseau","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.expneurol.2010.02.006_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ana.410440111","article-title":"Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases","volume":"44","author":"Holland","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2010.02.006_bib18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ctrv.2005.10.001","article-title":"Bortezomib, a novel proteasome inhibitor, in the treatment of hematologic malignancies","volume":"31","author":"Jackson","year":"2005","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.expneurol.2010.02.006_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2141.2004.05188.x","article-title":"A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma","volume":"127","author":"Jagannath","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.expneurol.2010.02.006_bib20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2141.2008.07359.x","article-title":"Updated survival analyses after prolonged follow-up of the phase 2, multicenter CREST study of bortezomib in relapsed or refractory multiple myeloma","volume":"143","author":"Jagannath","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.expneurol.2010.02.006_bib21","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1158\/1078-0432.CCR-07-0871","article-title":"Bortezomib for the treatment of mantle cell lymphoma","volume":"13","author":"Kane","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.expneurol.2010.02.006_bib22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1529-8027.2007.00130.x","article-title":"Evaluation of the long-term regenerative potential in an experimental nerve amputee model","volume":"12","author":"Lago","year":"2007","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.expneurol.2010.02.006_bib23","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/jnen\/63.10.1092","article-title":"CGRP peptide and regenerating sensory axons","volume":"63","author":"Li","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2010.02.006_bib24","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/cncr.21414","article-title":"Proteasome inhibition and its clinical prospects in the treatment of hematologic and solid malignancies","volume":"104","author":"Ludwig","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.expneurol.2010.02.006_bib25","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3324\/haematol.12106","article-title":"Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression","volume":"93","author":"Mateos","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.expneurol.2010.02.006_bib26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejpain.2009.07.001","article-title":"Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats","volume":"14","author":"Meregalli","year":"2009","journal-title":"Eur. J. Pain."},{"key":"10.1016\/j.expneurol.2010.02.006_bib27","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0306-4522(97)00258-3","article-title":"Calcitonin gene-related peptide increase in the rat spinal dorsal horn and dorsal column nucleus following peripheral nerve injury: up-regulation in a subpopulation of primary afferent sensory neurons","volume":"82","author":"Miki","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2010.02.006_bib28","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/jjco\/hym126","article-title":"Bortezomib in combination with conventional chemotherapeutic agents for multiple myeloma compared with bortezomib alone","volume":"37","author":"Min","year":"2007","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.expneurol.2010.02.006_bib29","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(00)80966-6","article-title":"IB4-binding DRG neurons switch from NGF to GDNF dependence in early postnatal life","volume":"19","author":"Molliver","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2010.02.006_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF02705243","article-title":"The ubiquitin-proteasome system","volume":"31","author":"Nandi","year":"2006","journal-title":"J. Biosci."},{"key":"10.1016\/j.expneurol.2010.02.006_bib31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0022-510X(93)90049-5","article-title":"Abnormalities of sympathetic sudomotor function in experimental acrylamide neuropathy","volume":"114","author":"Navarro","year":"1993","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2010.02.006_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/exnr.1994.1163","article-title":"Comparison of regenerative and reinnervating capabilities of different functional types of nerve fibers","volume":"129","author":"Navarro","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2010.02.006_bib33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jnr.490410113","article-title":"Innervation of cutaneous structures in the mouse hindpaw: a confocal microscopy immunocytochemical study","volume":"41","author":"Navarro","year":"1995","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2010.02.006_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neulet.2009.02.043","article-title":"Changes in calcitonin gene-related peptide expression following joint immobilization in rats","volume":"454","author":"Nishigami","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2010.02.006_bib35","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jpain.2007.01.004","article-title":"Characteristics of sensory dorsal root ganglia neurons innervating the lumbar vertebral body in rats","volume":"8","author":"Ohtori","year":"2007","journal-title":"J. Pain"},{"key":"10.1016\/j.expneurol.2010.02.006_bib36","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00001756-200103260-00034","article-title":"Degeneration of nociceptive nerve terminals in human peripheral neuropathy","volume":"12","author":"Pan","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2010.02.006_bib37","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2010.02.006_bib38","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1056\/NEJMoa030288","article-title":"A phase 2 study of bortezomib in relapsed, refractory myeloma","volume":"348","author":"Richardson","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2010.02.006_bib39","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa043445","article-title":"Bortezomib or high-dose dexamethasone for relapsed multiple myeloma","volume":"352","author":"Richardson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2010.02.006_bib40","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1200\/JCO.2005.04.7779","article-title":"Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib","volume":"24","author":"Richardson","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.expneurol.2010.02.006_bib41","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1200\/JCO.2008.18.3087","article-title":"Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy","volume":"27","author":"Richardson","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.expneurol.2010.02.006_bib42","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJMoa0801479","article-title":"Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma","volume":"359","author":"San Miguel","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2010.02.006_bib43","doi-asserted-by":"crossref","first-page":"18030","DOI":"10.1073\/pnas.0408345102","article-title":"Apoptotic and autophagic cell death induced by histone deacetylase inhibitors","volume":"101","author":"Shao","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2010.02.006_bib44","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/ncb1192","article-title":"Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes","volume":"6","author":"Shimizu","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.expneurol.2010.02.006_bib45","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1126\/science.1099993","article-title":"Autophagy in health and disease: a double-edged sword","volume":"306","author":"Shintani","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2010.02.006_bib46","first-page":"989","article-title":"Model for proteasome inhibition associated peripheral neuropathy","volume":"34","author":"Silverman","year":"2006","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.expneurol.2010.02.006_bib47","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.expneurol.2010.02.006_bib48","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/(SICI)1097-4598(199903)22:3<329::AID-MUS5>3.0.CO;2-8","article-title":"Physiological and immunohistochemical characterization of cisplatin-induced neuropathy in mice","volume":"22","author":"Verdu","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2010.02.006_bib49","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s102860200006","article-title":"New silicones for the evaluation of sudomotor function with the impression mold technique","volume":"12","author":"Vilches","year":"2002","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.expneurol.2010.02.006_bib50","first-page":"6316","article-title":"The proteasome as a target for cancer therapy","volume":"9","author":"Voorhees","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.expneurol.2010.02.006_bib51","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.1523\/JNEUROSCI.3051-05.2005","article-title":"Activin induces tactile allodynia and increases calcitonin gene-related peptide after peripheral inflammation","volume":"25","author":"Xu","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.02.006_bib52","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.expneurol.2004.06.015","article-title":"Overexpression of glial cell line-derived neurotrophic factor in the CNS rescues motoneurons from programmed cell death and promotes their long-term survival following axotomy","volume":"190","author":"Zhao","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2010.02.006_bib53","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.brainres.2007.10.044","article-title":"Calcitonin gene-related peptide dynamics in rat dorsal root ganglia and spinal cord following different sciatic nerve injuries","volume":"1187","author":"Zheng","year":"2008","journal-title":"Brain Res."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488610000610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488610000610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:44:59Z","timestamp":1758001499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488610000610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0014488610000610"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2010.02.006","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurophysiological, histological and immunohistochemical characterization of bortezomib-induced neuropathy in mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2010.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}